ArchiMed’s Fytexia acquires Milan’s B Natural

ArchiMed acquired natural ingredients company Fytexia in 2016 through its MED I fund, which raised €150 million in 2015.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this